Alone Self-Excited Induction Generators

In recent years, some converter structures and analyzing methods for the voltage regulation of stand-alone self-excited induction generators (SEIGs) have been introduced. However, all of them are concerned with the three-phase voltage control of three-phase SEIGs or the single-phase voltage control of single-phase SEIGs for the operation of these machines under balanced load conditions. In this paper, each phase voltage is controlled separately through separated converters, which consist of a full-bridge diode rectifier and one-IGBT. For this purpose, the principle of the electronic load controllers supported by fuzzy logic is employed in the two-different proposed converter structures. While changing single phase consumer loads that are independent from each other, the output voltages of the generator are controlled independently by three-number of separated electronic load controllers (SELCs) in two different mode operations. The aim is to obtain a rated power from the SEIG via the switching of the dump loads to be the complement of consumer load variations. The transient and steady state behaviors of the whole system are investigated by simulation studies from the point of getting the design parameters, and experiments are carried out for validation of the results. The results illustrate that the proposed SELC system is capable of coping with independent consumer load variations to keep output voltage at a desired value for each phase. It is also available for unbalanced consumer load conditions. In addition, it is concluded that the proposed converter without a filter capacitor has less harmonics on the currents

Search for time-dependent B0s - B0s-bar oscillations using a vertex charge dipole technique

We report a search for B0s - B0s-bar oscillations using a sample of 400,000 hadronic Z0 decays collected by the SLD experiment. The analysis takes advantage of the electron beam polarization as well as information from the hemisphere opposite that of the reconstructed B decay to tag the B production flavor. The excellent resolution provided by the pixel CCD vertex detector is exploited to cleanly reconstruct both B and cascade D decay vertices, and tag the B decay flavor from the charge difference between them. We exclude the following values of the B0s - B0s-bar oscillation frequency: Delta m_s < 4.9 ps-1 and 7.9 < Delta m_s < 10.3 ps-1 at the 95% confidence level.Comment: 18 pages, 3 figures, replaced by version accepted for publication in Phys.Rev.D; results differ slightly from first versio

Measurement of the Ratio of b Quark Production Cross Sections in Antiproton-Proton Collisions at 630 GeV and 1800 GeV

We report a measurement of the ratio of the bottom quark production cross section in antiproton-proton collisions at 630 GeV to 1800 GeV using bottom quarks with transverse momenta greater than 10.75 GeV identified through their semileptonic decays and long lifetimes. The measured ratio sigma(630)/sigma(1800) = 0.171 +/- .024 +/- .012 is in good agreement with next-to-leading order (NLO) quantum chromodynamics (QCD)

Search for time-dependent Bs0-Bs0 oscillations using exclusively reconstructed Ds±s mesons

A search for B0s-B0s oscillations is performed using a sample of 400 000 hadronic Z0 decays collected by the SLAC Large Detector experiment. The B0s candidates are reconstructed in the B0s→D-sX channel with D-s→Ππ-, K*0K-. The B0s production flavor is determined using the large forward-backward asymmetry of polarized Z0→bb decays and charge information in the hemisphere opposite that of the B0s candidate. The decay flavor is tagged by the charge of the D±s. From a sample of 361 candidates with an average B0s purity of 40%, we exclude the following values of the oscillation frequency: Δms&lt;1.4 ps-1 and 2.4&lt;Δms &lt;5.3 ps-1 at the 95% confidence level

Evaluation and Management of Dyslipidemia in Patients with HIV Infection

OBJECTIVE: Persons with HIV infection develop metabolic abnormalities related to their antiretroviral therapy and HIV infection itself. The objective of this study was to summarize the emerging evidence for the incidence, etiology, health risks, and treatment of dyslipidemias in HIV disease. DESIGN: Systematic review of original research with quantitative synthesis. MAIN RESULTS: Dyslipidemia is common in persons with HIV infection on highly active antiretroviral therapy (HAART), but methodologic differences between studies preclude precise estimates of prevalence and incidence. The typical pattern includes elevated total cholesterol, low-density lipoprotein cholesterol, and triglycerides, which may be markedly elevated. The dyslipidemia may be associated with lipodystrophy, insulin resistance, and, rarely, frank diabetes mellitus. Exposure to protease inhibitors (PIs) is associated with this entire range of metabolic abnormalities. PI-naïve patients on nucleoside reverse transcriptase inhibitors (NRTIs) may develop lipodystrophy, insulin resistance, hypercholesterolemia, and possibly modest elevations in triglycerides but not severe hypertriglyceridemia, which appears to be linked to PIs alone. Most studies have not found an association between CD4 lymphocyte count or HIV viral load and lipid abnormalities. The pathogenesis is incompletely understood and appears to be multifactorial. There are insufficient data to definitively support an increased coronary heart disease risk in patients with HIV-related dyslipidemia. However, some of the same metabolic abnormalities remain firmly established risk factors in other populations. Patients on HAART with severe hypertriglyceridemia may develop pancreatitis or other manifestations of the chylomicronemia syndrome. Some of the metabolic derangements (particularly hypertriglyceridemia) may improve upon replacing a PI with a non-nucleoside reverse transcriptase inhibitor. The limited experience suggests that fibrates, pravastatin, and atorvastatin can safely treat lipid abnormalities in HIV-infected patients. CONCLUSIONS: Patients with HIV infection on HAART should be screened for lipid disorders, given their incidence, potential for morbidity, and possible long-term cardiovascular risk. Treatment decisions are complex and must include assessments of cardiac risk, HIV infection status, reversibility of the dyslipidemia, and the effectiveness and toxicities of lipid-lowering medications. The multiple potential drug interactions with antiretroviral or other HIV-related medications should be considered in lipid-lowering drug selection and monitoring

B(s) mixing at SLD

We set a preliminary 95% C.L. exclusion on the oscillation frequency of $B_s^0 - \bar{B_s^0}$ mixing using a sample of 400,000 hadronic $Z^0$ decays collected by the SLD experiment at the SLC during the 1996-98 run. Three analyses are presented in this paper. The first analysis partially reconstructs the $B_s^0$ by combining a fully reconstructed $D_s$ with the remaining charged B decay tracks. The second analysis selects a sample of events with a partially reconstructed charm vertex and a lepton track. The third analysis reconstructs b-hadrons topologically and exploits the $b \to c$ cascade charge structure to determine the flavor of the b-hadron at decay. All three analyses take advantage of the large forward-backward asymmetry of the polarized $Z^0 \to b \bar{b}$ decays and information in the hemisphere opposite to the reconstructed B vertex to determine the b-hadron flavor at production. The results of the three analyses are combined to exclude the following values of the $B_s^0 - \bar{B_s^0}$ oscillation frequency: $\Delta m_s < 7.6 ps^{-1}$ and $11.8 < \Delta m_s < 14.8 ps^{-1}$ at the 95% confidence level.Comment: 6 pages, 1 figure, contributed to the proceedings of DPF200